brand logo

Am Fam Physician. 2024;109(4):369-370

Author disclosure: No relevant financial relationships.

Clinical Question

Are adolescents with a history of cannabis use more likely to develop increased suicidality in adulthood?

Evidence-Based Answer

Adolescents with a history of cannabis use have at least a 50% increase in the odds of developing suicidality in adulthood. (Strength of Recommendation: B, large meta-analysis of cohort studies consistent with an additional cohort and cross-sectional twin study.)

Evidence Summary

A 2019 systematic review and meta-analysis (11 prospective cohort studies; n = 23,317) assessed the association between adolescent cannabis use and the risk of developing depression, anxiety, and suicidality in young adulthood.1 Included studies enrolled patients younger than 18 years and assessed their cannabis use before 18 years of age with self-reported questionnaires that measured frequency of use over the past 6 to 12 months. Patients with any reported use were pooled and compared with nonusers. All studies individually adjusted the odds ratios (ORs) based on several suspected confounding variables, including a history of depression, alcohol use, sex, or tobacco use. The primary outcomes included rates of suicidal ideation and suicide attempts, assessed by questionnaire or standardized interview assessments at least once between 18 and 32 years of age. A history of cannabis use in adolescence was associated with a 50% increase in the odds of suicidal ideation (three studies; n = 8,479; OR = 1.5; 95% CI, 1.1 to 2.0) and more than a threefold increase in the odds of a suicide attempt (three studies; n = 13,687; OR = 3.4; 95% CI, 1.5 to 7.8) in adulthood. Some studies did not account for potential confounders such as tobacco or other drug use and comorbid psychosocial factors. The exact type, quantity, and potency of cannabis consumed among the studied adolescents were not measured or reported.

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

Help Desk Answers provides answers to questions submitted by practicing family physicians to the Family Physicians Inquiries Network (FPIN). Members of the network select questions based on their relevance to family medicine. Answers are drawn from an approved set of evidence-based resources and undergo peer review. The strength of recommendations and the level of evidence for individual studies are rated using criteria developed by the Evidence-Based Medicine Working Group (https://www.cebm.net).

The complete database of evidence-based questions and answers is copyrighted by FPIN. If interested in submitting questions or writing answers for this series, go to https://www.fpin.org or email: questions@fpin.org.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of FPIN’s Help Desk Answers published in AFP is available at https://www.aafp.org/afp/hda.

Continue Reading

More in AFP

More in PubMed

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.